Psychiatry & Neurology Doctors in Emeryville, CA Accepting Medicare

5 Psychiatry & Neurology doctors found. Showing 1 - 5

John Church, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2340 Powell St, #402, Emeryville, CA 94608 Phone: 800-451-7811    Fax: 888-777-2067

Moremi Abeni Gravesandy Vassall, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1480 64th St Ste 150, Emeryville, CA 94608 Phone: 925-282-1778    Fax: 415-296-5299

Shahla Moghbel, Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 2100 Powell St, Emeryville, CA 94608 Phone: 510-350-2600

Dr. Howard Fields, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 5858 Horton St, Suite 200, Emeryville, CA 94608 Phone: 510-985-3971

Dr. Robert Rafal, Psychiatry & Neurology - Behavioral Neurology & Neuropsychiatry Medicare: Not Enrolled in Medicare Practice Location: 3 Captain Dr, Apt D404, Emeryville, CA 94608 Phone: 805-695-9044

News Archive

Recql5 identified as a tumor suppressor in GI tract

Recql5 is a member of the mammalian RecQ helicase family. Genetic mutations that result in loss of RecQ helicase activity give rise to disorders that are associated with cancer predisposition and premature aging, such as Bloom, Werner, and Rothmund-Thomson syndromes. This class of enzymes is best known for their role in maintaining the integrity of the genome to prevent oncogenic mutations.

Va. Senate Republican offers proposal on Medicaid impasse

State Sen. Emmett Hanger seeks a compromise on the issue that threatens to shut down the state government because it has deadlocked negotiations on the budget.

FDA clears Accuray's new CyberKnife M6 Series

Accuray Incorporated, the premier radiation oncology company, today announced that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife M6 Series.

Stapled Peptides directly inhibit the Notch transcription factor complex

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex."

Read more Medical News

› Verified 3 days ago